Spinifex Pharmaceuticals is a clinical-stage Australian biotechnology company specialising in the development of products for the treatment of pain.
Attendance at Biotech Showcase
Tom McCarthy, CEO of Spinifex Pharmaceuticals, will be attending and presenting at the Biotech Showcase conference on 10 January 2012 in the Track A room at 2:15pm, to be held at the Parc 55 Wyndham San Francisco-Union Square in San Francisco.
Latest News & Events
23RD DECEMBER 2011 Spinifex set to present at the Biotech Showcase 2012 conference in San Francisco ... More
6TH DECEMBER 2011 Appointment of Spinifex Non-Executive Chairman. ... More
19TH SEPTEMBER 2011 Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia ... More